Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)

Detalles Bibliográficos
Autores principales: Jacoby, Meagan A., Finn, Laura, Emadi, Ashkan, Saba, Nakhle S., Powell, Bayard L., Seiter, Karen, Garcia, Rosella, Faderl, Stefan, Male, Heather J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102836/
https://www.ncbi.nlm.nih.gov/pubmed/33974493
http://dx.doi.org/10.1080/10428194.2021.1919668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102836/
https://www.ncbi.nlm.nih.gov/pubmed/33974493
http://dx.doi.org/10.1080/10428194.2021.1919668

Ejemplares similares